Characterization of a selective inhibitor of the Parkinson's disease kinase LRRK2.

ABSTRACT: Mutations in leucine-rich repeat kinase 2 (LRRK2) are strongly associated with late-onset autosomal dominant Parkinson's disease. We employed a new, parallel, compound-centric approach to identify a potent and selective LRRK2 inhibitor, LRRK2-IN-1, and demonstrated that inhibition of LRRK2 induces dephosphorylation of Ser910 and Ser935 and accumulation of LRRK2 within aggregate structures. LRRK2-IN-1 will serve as a versatile tool to pharmacologically interrogate LRRK2 biology and study its role in Parkinson's disease.

SUBMITTER: Deng X 

PROVIDER: S-EPMC3287420 | biostudies-literature | 2011 Apr

REPOSITORIES: biostudies-literature